In an attempt to elucidate the biology of host defense against Haemophilus influenzae type b, we previously studied the ability of serum to enhance the phagocytosis of this organism by human leukocytes (1, 2, 5, 6) . Serum from normal adults containing its own complement activity exhibited significant phagocytosis-promoting (opsonizing) activity, whereas serum from four of five children with congenital agammaglobulinemia and one patient with C3 deficiency lacked such activity (1, 5) . Serum from adults vaccinated with the capsular polysaccharide of type b H. influenzae showed a prompt and sustained rise in opsonizing activity after vaccination (2) . Specific immunoglobulin (Ig)G, anticapsular antibody purified by affinity chromatography from postvaccination serum had opsonizing, as well as bactericidal and hemagglutinating activity in the presence of added complement (6) .
Since almost all sera with opsonizing activity also had bactericidal activity, the question The bacterium (ATCC strain 9795) was maintained as previously described (1) . A log-phase culture was centrifuged at 5,000 x g, resuspended in Levinthals broth to an optical density of 0.070 at 590 nm (3) , and then diluted with 20 volumes of broth. A previously described modification of the method of Quie (10) was used to study phagocytic bactericidal activity (3) , except as noted here. The reaction mixture consisted of 2.5 x 106 peripheral blood phagocytes (primarily neutrophils) in 0.6 ml of KrebsRinger phosphate buffer, approximately 4 x 106 bacteria in 0.3 ml of broth, and 0.1 ml of high-titered immune serum from an adult vaccinated with capsular polysaccharide (2) or serum from a pool of nine normal adults. Sera were processed to preserve complement activity (8) and thus served as their own complement source. The immune serum had a hemagglutination titer of 1: 256 and a bactericidal titer of 1: 128, and the normal serum had a hemagglutination titer of 1: 8; all assays were performed by Porter Anderson, using published techniques (1) . Enrichment medium (Isovitalex, BBL Division) (1% vol/vol) was added to the KrebsRinger phosphate buffer, which also contained 0.2% glucose and 0.2% bovine serum albumin. Dilutions of the reaction mixture (1:180 and then 1: 18) were made in 9 ml of 0.4% bovine serum albumin, and leukocytes were disrupted at both dilutions by sonic disruption in a "cup horn" (Heat Systems-Ultrasonics, Inc., Plain-VOL. 8, 1973 view, N.Y.) for (Fig. 1B) , in agreement with previous studies showing decreased but definite opsonization by heated immune serum (5) . When leukocytes and bacteria were suspended in buffer from which growth factors for H. influenzae had been deleted, the number of viable bacteria remained approximately constant for 60 min in the presence of phagocytes alone or in the absence of serum and phagocytes, but the bactericidal effect of pooled normal serum was marked (Fig. 1C) . In the presence of 0.05 ml of immune serum, bacterial killing was almost identical to that shown here with 0.1 ml of normal serum (data not plotted).
Rapid killing of bacteria by phagocytes, reported here for type b H. influenzae, has been described with other extracellular bacteria (8) (9) (10) . When the in vitro milieu was favorable for growth of H. influenzae, the bactericidal effect of immune serum alone was negligible, whereas that of serum and phagocytes was marked. This is in contrast to the efficient bacteriolysis achieved by immune or normal serum when we used a buffer which did not permit bacterial growth, and to the findings of Ward and Wright (11) , in which serum bactericidal activity was so effective that the killing achieved by phagocytes could not be clearly determined. These differences demonstrate the importance of the suspending medium to results obtained, using H. influenzae in phagocytic bactericidal assays, and emphasize that caution must be exercised in extrapolating from in vitro results to the in vivo situation. In this regard, the ability of H. influenzae to multiply in the suspending medium of an assay would seem to approximate the in vivo situation more closely than an inability to do so. For this reason, it would perhaps be advisable that the bacteria be able to multiply in the absence of the test serum in any assay of serum or phagocytic bactericidal activity designed to estimate the status of immunity in the patient.
Considerable indirect evidence has accumulated in recent years to indicate that extracellular pathogens (pyogenic and most enteric bacteria) must be cleared from the body primarily by the process of phagocytosis. Our results do not prove that the role of serum in host defense against H. influenzae is mediated through opsonization rather than bacteriolysis, but they do remove the theoretical objection to this viewpoint posed by the inability to separate serum bactericidal from opsonizing activity in vitro. In agreement with the concept that bacteriolysis plays a minor role in host defense are the findings that patients with a leukocyte defect of phagocytic killing often die from infections due to enteric bacteria, which are easily killed by serum in vitro (7) , and that a patient with absence of the sixth complement component (and thus absence of bacteriolysis but not opsonization) had had no difficulty with infections (J. P. Leddy, M. M. Frank, T. Gaither, R. S. Heuskinveld, R. T. Breckinridge, and M. R. Klemperer, J. Clin. Invest. 52: 50a, 1972).
